The newly published report by IMARC Group, titled, ”Geographic Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the geographic atrophy market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the global market. The report also highlights key segments and market drivers, as well as challenges faced by industry players.
Geographic atrophy represents an advanced form of dry age-related macular degeneration that affects the retina, a part of the eye that sends information to the brain to enable sight. In this stage, the damage is so severe that it causes blind spots in the central vision of the patient. The common symptoms experienced by patients are central vision loss, difficulty in low-light conditions, and trouble seeing colors. An ophthalmologist can identify geographic atrophy using retinal imaging and a dilated examination.
Request a Free Sample Report:
https://www.imarcgroup.com/geographic-atrophy-market/requestsample
The growing prevalence of retinal disorders and the expanding geriatric population are among the key factors stimulating the geographic atrophy market. Moreover, the increasing incidences of obesity and cardiovascular diseases (CVDs), on account of changing dietary patterns, sedentary lifestyles, and unhealthy habits, such as smoking, are acting as significant growth-inducing factors. Besides this, the rising usage of smartphones, laptops, televisions, etc., leading to prolonged and excessive screen time, is positively influencing the global market. Furthermore, the introduction of retinal gene therapies, which involve injecting adeno-associated virus (AAV) into the body to prevent the development of abnormal blood vessels, is also propelling the market growth.
Apart from this, the widespread adoption of autofluorescence imaging technology to visualize the retinal pigment epithelium (RPE) to assess the progression rate of the disease is further fueling the global market. Additionally, the inflating investments by various key players in developing imaging technologies, which will contribute to understanding the genesis and pathophysiological mechanisms of geographic atrophy, are also driving the market growth. In addition to this, the extensive R&D activities for launching innovative and effective drugs and the increasing expenditure on healthcare to facilitate access to affordable treatment options are anticipated to fuel the geographic atrophy market over the forecasted period.
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the geographic atrophy market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the geographic atrophy market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Ask an Analyst for Report Customization with TOC & List of figures:
https://www.imarcgroup.com/geographic-atrophy-market
Key Questions Answered in this Report:
- How has the geographic atrophy market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the geographic atrophy market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the geographic atrophy market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Browse the Latest Research Report:
Idiopathic Pulmonary Fibrosis (IPF) Market Report 2023-2033
Diabetic Neuropathy Market Report 2023-2033
Metachromatic Leukodystrophy Market Report 2023-2033
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800